Assessing EGFR mutations

N Engl J Med. 2006 Feb 2;354(5):526-8; author reply 526-8. doi: 10.1056/NEJMc052564.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Carcinoma, Non-Small-Cell Lung / genetics*
  • Carcinoma, Non-Small-Cell Lung / mortality
  • Colonic Neoplasms / genetics
  • DNA Mutational Analysis / methods
  • ErbB Receptors / genetics*
  • Erlotinib Hydrochloride
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / mortality
  • Mutation*
  • Paraffin Embedding
  • Polymerase Chain Reaction
  • Protein Kinase Inhibitors / therapeutic use*
  • Quinazolines / therapeutic use*
  • Sequence Deletion
  • Survival Analysis

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • Erlotinib Hydrochloride
  • ErbB Receptors